ArticlePediatric blood & cancer2018
Parent understanding of the risk of future limitations secondary to pediatric cancer treatment.
Article in Pediatric blood & cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Multilevel barriers and facilitators of communication in pediatric oncology: A systematic review.Pediatric blood & cancer · 2022Pooled it
- Development and pre-testing of a family-centered digital intervention to help families know what to EXPECT from pediatric acute lymphoblastic leukemia therapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Managing Conflicting Prognostic Communication Preferences in Pediatric Oncology.JAMA network open · 2026Article
- Preferences for Communication About Prognosis Among Children With Cancer, Parents, and Oncologists.JAMA network open · 2025Article
- "A very difficult conversation": Challenges and opportunities for improvement in pediatric oncology clinician communication about late effects.Pediatric blood & cancer · 2024Article
- "There's no playbook for when your kid has cancer": Desired elements of an electronic resource to support pediatric cancer communication.Pediatric blood & cancer · 2023Article
- Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study.BMC cancer · 2022Article
- Early parental knowledge of late effect risks in children with cancer.Pediatric blood & cancer · 2022Article
- Conflicting goals and obligations: Tensions affecting communication in pediatric oncology.Patient education and counseling · 2022Article
- Educational Pain Points for Pediatric Brain Tumor Survivors: Review of Risks and Remedies.Children (Basel, Switzerland) · 2021Review
- Perceptions and knowledge of air pollution and its health effects among caregivers of childhood cancer survivors: a qualitative study.BMC cancer · 2021Article
- "Don't be afraid to speak up": Communication advice from parents and clinicians of children with cancer.Pediatric blood & cancer · 2021Article
- Prognostic Communication Between Oncologists and Parents of Children With Advanced Cancer.Pediatrics · 2021Article
- Assume It Will Break: Parental Perspectives on Negative Communication Experiences in Pediatric Oncology.JCO oncology practice · 2021Article
- Parental distress and desire for information regarding long-term implications of pediatric cancer treatment.Cancer · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundParents and physicians may have different understandings of a child's risk of future limitations due to cancer or cancer treatment. We evaluated alignment between parent- and physician-estimated risk of late effects.
methodsWe surveyed 352 parents of children with cancer within 12 weeks of diagnosis, and the children's oncologists, at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Children's Hospital of Philadelphia. We assessed parent and physician estimations of the child's risk of future limitations in physical abilities, intelligence, or quality of life (QOL) due to cancer treatment. Physician-estimated risk of limitations ≥50% was considered high risk.
resultsPhysicians considered 22% of children at high risk of physical impairments, 9% at high risk for impaired intelligence, and 6% at high risk for impaired QOL. Among high-risk children, 38% of parents recognized this risk in physical abilities, 21% in intelligence, and 5% in QOL. In multivariable analysis, parental understanding of risk, defined as concordant parent and physician estimates, was greater among parents of children at lower risk of future limitations (odds ratio 2.59; 95% confidence interval 1.35-4.96). Regardless of risk, 92% of parents considered it very/extremely important to receive information about potential health implications of cancer treatment.
conclusionsAlthough most parents want information about life after cancer, most parents of children at high risk of future impairment do not recognize this risk. Strategies to improve communication about late effects throughout pediatric cancer treatment should prioritize meeting information needs and improving parent understanding of the risk of impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.